1. The frequency of epithelial ovarian cancer subtypes in Sudanese women at Omdurman Maternity Hospital, 2013-2018: A cross-sectional study
   Rawia Eljaili Elmassry et al, 2019, F1000Res CrossRef
2. Herbal Active Ingredients: An Emerging Potential for the Prevention and Treatment of Papillary Thyroid Carcinoma
   Yang Yang et al, 2020, BioMed Research International CrossRef
3. Optimized Icariin Phytosomes Exhibit Enhanced Cytotoxicity and Apoptosis-Inducing Activities in Ovarian Cancer Cells
   Nabil A. Alhakamy et al, 2020, Pharmaceutics CrossRef
4. Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer
   Bartosz Mateusz Gąsiorkiewicz et al, 2020, Invest New Drugs CrossRef
5. The Hallmarks of Flavonoids in Cancer
   Luis Gustavo Saboia Ponte et al, 2021, Molecules CrossRef
6. Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo
   Gaojie Song et al, 2022, Invest New Drugs CrossRef
7. Focusing on the Role of Natural Products in Overcoming Cancer Drug Resistance: An Autophagy-Based Perspective
   Jiaqi Yao et al, 2022, Biomolecules CrossRef
8. Screening Multidrug Resistance Reversal Agents in Traditional Chinese Medicines by Efflux Kinetics of D-Luciferin in MCF-7/DOXFluc Cells
   Yue Zhao et al, 2023, ACS Omega CrossRef
9. Icariin as a potential anticancer agent: a review of its biological effects on various cancers
   Fang-Yuan Liu et al, 2023, Front. Pharmacol. CrossRef
10. Exploiting Nanotechnology for Drug Delivery: Advancing the Anti-Cancer Effects of Autophagy-Modulating Compounds in Traditional Chinese Medicine
    Zixian Liu et al, 2024, IJN CrossRef
11. Cancer-Related Therapeutic Potential of Epimedium and Its Extracts
    Jipeng Ding et al, 2024, Nutrition and Cancer CrossRef
12. Icariin inhibits cisplatin-induced ovarian toxicity via modulating NF-κB and PTEN/AKT/mTOR/AMPK axis
    Basma G. Eid et al, 2024, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef